Global Corruption Report 2006

Více o knize

TI has demonstrated its ability to merge research and policy analysis to illuminate the pervasive issues of corruption while proposing progressive solutions. In the health sector, corruption poses serious risks, manifesting in various forms: medical professionals selling essential medicines, government officials embezzling health funds, and pharmaceutical companies exerting influence over research. The consequences are dire for patients, who may face exorbitant costs or receive unsafe, counterfeit medications. The 2006 edition of Transparency International’s Global Corruption Report highlights corruption's impact on healthcare across both affluent and impoverished nations. Case studies reveal high-level bribery in Costa Rica and informal payments in Hungary, illustrating the sector's vulnerability to corruption. A special section addresses corruption in HIV/AIDS, emphasizing the need to protect substantial investments aimed at combating major diseases. Additionally, the report provides an in-depth analysis of the pharmaceutical industry's challenges. It includes an annual overview of global developments and tracks significant trends in over 40 countries. This report is a unique and vital resource for anyone seeking the latest insights on how corruption affects various sectors, including health, education, and energy.